Tolazamide

Back to search

Molecule Structure

Scientific Name

Tolazamide

Description of the Drug

Tolazamide is a sulfonylurea used in the treatment of non insulin dependent diabetes mellitus.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00839

Brand Name(s)

Tolazamide, Tolinase

Company Owner(s)

Mylan Pharmaceuticals Inc, Watson Laboratories Inc, Barr Laboratories Inc, Cosette Pharmaceuticals Inc, Usl Pharma Inc, Chartwell Rx Sciences Llc, Sun Pharmaceutical Industries Inc, Superpharm Corp, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Pharmacia And Upjohn Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sulfonylurea receptor 1, Kir6.2 PROTEIN COMPLEX BLOCKER CHEMBL2096972

Unichem Links

SureChEMBL SCHEMBL34417
PharmGKB PA164774902
Human Metabolome Database HMDB0014977
WDI TOLAZAMID
DrugBank DB00839
PubChem: Thomson Pharma 14850072
PubChem 5503
Mcule MCULE-9265102499
LINCS LSM-2699
Nikkaji J3.663C
BindingDB 50240099
EPA CompTox Dashboard DTXSID3021358
DrugCentral 2694
ChemicalBook CB9355686
Guide to Pharmacology 6847
GSRS a89b65c2-c968-46ce-bef3-496eef85e404
rxnorm TOLAZAMIDE
ChEBI 9613
NIH Clinical Collection SAM002564236
ZINC ZINC000000057512